{"disease":{"id":"metastasis","name":"metastasis"},"drugs":{"marketed":[{"drug_id":"aflibercept","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vegf Trap","generic_name":"AFLIBERCEPT","company_name":"Regeneron","drug_phase":"marketed","molecular_target":"Vascular endothelial growth factor A","drug_class":"Vascular Endothelial Growth Factor Inhibitor","quality_score":55,"revenue":"9800","mechanism":""},{"drug_id":"enzalutamide","indication_name":"Metastasis from malignant tumor of prostate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xtandi","generic_name":"enzalutamide","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"Androgen Receptor Inhibitor [EPC]","quality_score":10,"revenue":"4500","mechanism":"Xtandi works by blocking the androgen receptor, a protein that helps prostate cancer cells grow."},{"drug_id":"apalutamide","indication_name":"Metastasis from malignant tumor of prostate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Erleada","generic_name":"apalutamide","company_name":"Johnson & Johnson","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"","quality_score":65,"revenue":"2600","mechanism":"Erleada blocks the androgen receptor, a protein that helps cancer cells grow."},{"drug_id":"selpercatinib","indication_name":"Metastasis from malignant tumor of thyroid","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Retevmo","generic_name":"SELPERCATINIB","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"Proto-oncogene tyrosine-protein kinase receptor Ret","drug_class":"Kinase Inhibitor [EPC]","quality_score":69,"revenue":"700","mechanism":"Retevmo works by blocking the activity of the RET protein, which is involved in the growth and spread of cancer cells."},{"drug_id":"regorafenib","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Stivarga","generic_name":"regorafenib","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Bifunctional epoxide hydrolase 2","drug_class":"Kinase Inhibitor","quality_score":86,"revenue":"400","mechanism":"Stivarga blocks the activity of enzymes involved in tumor growth and angiogenesis."},{"drug_id":"xtandi","indication_name":"Metastasis from malignant tumor of prostate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xtandi","generic_name":"xtandi","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Androgen receptor","drug_class":"Androgen receptor inhibitor","quality_score":10,"revenue":null,"mechanism":"Enzalutamide competitively inhibits androgen binding to androgen receptors, blocking nuclear translocation and DNA interaction."},{"drug_id":"irinotecan","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camptosar","generic_name":"irinotecan","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"topoisomerase I","drug_class":"Topoisomerase Inhibitor","quality_score":76,"revenue":null,"mechanism":"Irinotecan and its metabolite SN-38 bind to the topoisomerase I-DNA complex, preventing DNA repair and causing double-strand breaks."},{"drug_id":"fluorouracil","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"fluorouracil","company_name":"Extrovis","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"irinotecan-hydrochloride","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camptosar","generic_name":"Irinotecan Hydrochloride","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Topoisomerase Inhibitor","quality_score":79,"revenue":null,"mechanism":"Camptosar works by blocking the enzyme topoisomerase I, which is necessary for DNA replication, thereby preventing cancer cells from dividing and growing."},{"drug_id":"flotufolastat","indication_name":"prostate cancer with suspected metastasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Posluma","generic_name":"FLOTUFOLASTAT","company_name":"Blue Earth","drug_phase":"marketed","molecular_target":"","drug_class":"Radioactive Diagnostic Agent [EPC]","quality_score":60,"revenue":null,"mechanism":"Posluma works by emitting radiation that helps doctors visualize and diagnose prostate cancer."},{"drug_id":"aromatase-inhibitor","indication_name":"Adjuvant treatment of hormone receptor-positive breast cancer in postmenopausal women with disease recurrence or metastasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aromatase inhibitor","generic_name":"aromatase-inhibitor","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Aromatase inhibitor","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"adjuvant-letrozole-postmenopausal-women","indication_name":"Adjuvant treatment of hormone receptor-positive invasive breast cancer in postmenopausal women with disease recurrence or metastasis after 2-3 years of tamoxifen therapy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Adjuvant letrozole (postmenopausal women)","generic_name":"adjuvant-letrozole-postmenopausal-women","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"aromatase","drug_class":"aromatase inhibitor","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"onivyde","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Camptosar","generic_name":"onivyde","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Acetylcholinesterase","drug_class":"Topoisomerase Inhibitor","quality_score":74,"revenue":null,"mechanism":"Camptosar works by inhibiting topoisomerase I, an enzyme that helps DNA replicate, causing DNA damage and cancer cell death."},{"drug_id":"sama","indication_name":"Pain due to Osteoblastic Bone Metastasis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SAMA","company_name":"Lantheus Medical","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":"Sama is a small molecule that works by interacting with a specific biological target to produce a therapeutic effect."},{"drug_id":"xeloda","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Xeloda","company_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"5-fu","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Carac","generic_name":"5-fu","company_name":"Spectrum Pharms","drug_phase":"marketed","molecular_target":"Aromatase","drug_class":"Nucleoside Metabolic Inhibitor","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"capecitabine","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Xeloda","generic_name":"capecitabine","company_name":"Cheplapharm","drug_phase":"marketed","molecular_target":"Thymidylate synthase","drug_class":"Nucleoside Metabolic Inhibitor [EPC]","quality_score":67,"revenue":null,"mechanism":"Xeloda works by inhibiting the enzyme thymidylate synthase, which is necessary for DNA synthesis in cancer cells."},{"drug_id":"oxaliplatin","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eloxatin","generic_name":"Oxaliplatin","company_name":"Yakult Honsha","drug_phase":"marketed","molecular_target":"DNA","drug_class":"Platinum-based chemotherapy agent","quality_score":70,"revenue":null,"mechanism":"Oxaliplatin forms platinum-DNA crosslinks that inhibit replication and transcription."},{"drug_id":"eylea","indication_name":"Metastasis from malignant tumor of colon","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Eylea","company_name":"Texas Retina Associates","drug_phase":"marketed","molecular_target":"Placenta growth factor, Vascular endothelial growth factor A, Vascular endothelial growth factor B","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"mdv3100","indication_name":"Metastasis from malignant tumor of prostate","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"MDV3100","generic_name":"mdv3100","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"Androgen receptor, Glucocorticoid receptor, Prostate-specific antigen","drug_class":"Androgen receptor inhibitor","quality_score":17,"revenue":null,"mechanism":""}],"pipeline":[{"drug_id":"pf-07265807","indication_name":"Neoplasm Metastasis","indication_type":"pipeline","phase":"discontinued","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"PF-07265807","generic_name":"pf-07265807","company_name":"Pfizer Inc.","drug_phase":"discontinued","molecular_target":"","drug_class":"Given 2 weeks on/1 week off","quality_score":null,"revenue":null,"mechanism":"Given 2 weeks on/1 week off"}],"offLabel":[],"totalMarketed":20,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT03567538","title":"National Register Studies in Thoracic Surgery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT07153783","title":"Interventional AI-Human Collaboration for Liver Tumor Diagnosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":10333,"lead_sponsor_name":"Shengjing Hospital","has_results":false},{"nct_id":"NCT06517979","title":"Development and Prospective Validation of a Digital Pathology-based Artificial Intelligence Diagnostic Model for Pan-cancer Lymphatic Metastasis","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT06684418","title":"Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT06787014","title":"Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study","phase":"","overall_status":"RECRUITING","enrollment_count":3200,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT04416165","title":"Comparison of FDG and FAPI in Patients With Various Types of Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"The First Affiliated Hospital of Xiamen University","has_results":false},{"nct_id":"NCT04574245","title":"Gastric Cancer Liver Metastasis Cohort of China","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT06046131","title":"Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Guadeloupe","has_results":false},{"nct_id":"NCT06135571","title":"Study on the No.253 Lymph Node Metastasis Patterns in Left-Sided Colon and Rectal Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT00339664","title":"Analyses of Human Samples Collected in Clinical Trials","phase":"","overall_status":"COMPLETED","enrollment_count":2579,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04281784","title":"Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)","phase":"NA","overall_status":"COMPLETED","enrollment_count":2512,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT06001528","title":"Serum and Tissue Metabolite-based Prediction of Sentinel Lymph Node Metastasis in Breast Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2400,"lead_sponsor_name":"Shantou Central Hospital","has_results":false},{"nct_id":"NCT04989192","title":"Dose Efficiency of Modern CT Scanners in Oncologic Scans","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2400,"lead_sponsor_name":"University Hospital Augsburg","has_results":false},{"nct_id":"NCT00338286","title":"A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2098,"lead_sponsor_name":"Janssen Research & Development, LLC","has_results":true},{"nct_id":"NCT05933876","title":"The Impact of Radiotherapy on Oligometastatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT06399159","title":"Prediction of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma Based on Ultrasound and Cytological Images","phase":"","overall_status":"COMPLETED","enrollment_count":1500,"lead_sponsor_name":"Nanchong Central Hospital","has_results":false},{"nct_id":"NCT06179602","title":"Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT04116125","title":"Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1380,"lead_sponsor_name":"Kyungpook National University Chilgok Hospital","has_results":false},{"nct_id":"NCT06256185","title":"Machine Learning to Predict Lymph Node Metastasis in T1 Esophageal Squamous Cell Carcinoma","phase":"NA","overall_status":"COMPLETED","enrollment_count":1267,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06957678","title":"AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1200,"lead_sponsor_name":"Qun Zhao","has_results":false},{"nct_id":"NCT07035587","title":"Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT06883084","title":"Clinical Relevance of Pathologic Regression IN Lymph Node for Locally Advanced Rectal Cancer","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1080,"lead_sponsor_name":"Yanhong Deng","has_results":false},{"nct_id":"NCT07180641","title":"National Registry of Hepatic Metastases From Non-Colorectal Cancer\"","phase":"","overall_status":"COMPLETED","enrollment_count":1039,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT05707312","title":"Staging Endometrial caNcer Based on molEcular ClAssification","phase":"","overall_status":"UNKNOWN","enrollment_count":1032,"lead_sponsor_name":"Clinica Universidad de Navarra, Universidad de Navarra","has_results":false},{"nct_id":"NCT06527027","title":"LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Copernicus Memorial Hospital","has_results":false},{"nct_id":"NCT07319104","title":"Liquid Biopsy in Early Colorectal Lesions","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05480189","title":"Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Zhejiang Cancer Hospital","has_results":false},{"nct_id":"NCT06478368","title":"Prediction of Occult Peritoneal Metastasis of Locally Advanced Gastric Cancer Using Multimodal Data Based on Artificial Intelligence Combined With Intraoperative Dynamic Video","phase":"","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Qun Zhao","has_results":false},{"nct_id":"NCT06718972","title":"A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Guangzhou Medical University","has_results":false},{"nct_id":"NCT07385521","title":"The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Francesco De Cobelli","has_results":false},{"nct_id":"NCT03721952","title":"Facilitating Communication Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":977,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT05845632","title":"Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":965,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT05596578","title":"Role of Intrapulmonary Lymph Nodes in Patients With NSCLC and Visceral Pleural Invasion","phase":"","overall_status":"RECRUITING","enrollment_count":958,"lead_sponsor_name":"Luzerner Kantonsspital","has_results":false},{"nct_id":"NCT06623578","title":"Comparative Study of Transaxillary Robotic Thyroidectomy With MRND Versus Conventional Open Surgery in N1b PTC","phase":"NA","overall_status":"RECRUITING","enrollment_count":876,"lead_sponsor_name":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","has_results":false},{"nct_id":"NCT05352178","title":"Metastasis-directed Therapy for Oligorecurrent Prostate Cancer","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":873,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT03927287","title":"Prognostic Role of Free Psa Ratio at Biochemical Recurrence After Radical Treatments for Prostate Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":822,"lead_sponsor_name":"Rabin Medical Center","has_results":false},{"nct_id":"NCT06563388","title":"Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":false},{"nct_id":"NCT05573893","title":"PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07042984","title":"RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":800,"lead_sponsor_name":"Fujian Medical University","has_results":false},{"nct_id":"NCT05943951","title":"Italian Study on the Right Hemicolectomy: How the Lymphadenectomy is Performed","phase":"","overall_status":"COMPLETED","enrollment_count":788,"lead_sponsor_name":"Gabriele Anania","has_results":false},{"nct_id":"NCT07155954","title":"Value of Super-resolution Ultrasonography in Differentiating Benign and Malignant Lymph Nodes","phase":"","overall_status":"RECRUITING","enrollment_count":779,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT04283994","title":"Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)","phase":"NA","overall_status":"COMPLETED","enrollment_count":756,"lead_sponsor_name":"University of Washington","has_results":true},{"nct_id":"NCT00781612","title":"A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":720,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT01996306","title":"A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":650,"lead_sponsor_name":"Epidemiological and Clinical Research Information Network","has_results":false},{"nct_id":"NCT06476639","title":"A Phase III Randomised Clinical Trial of Ultrasound Groin Monitoring Versus Groin Lymph Node Dissection to De-Escalate the Extent of Surgery in Vulvar Cancer","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":640,"lead_sponsor_name":"Queensland Centre for Gynaecological Cancer","has_results":false},{"nct_id":"NCT06031246","title":"Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":634,"lead_sponsor_name":"Fudan University","has_results":false},{"nct_id":"NCT04622423","title":"Advanced Therapies for Liver Metastases","phase":"","overall_status":"RECRUITING","enrollment_count":625,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT04890522","title":"An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":622,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT03588416","title":"Multicentric Study About Pathological Risk Factors for Lymph Node Metastasis in Malignant Colorectal Polyps","phase":"","overall_status":"UNKNOWN","enrollment_count":615,"lead_sponsor_name":"Dario Parini","has_results":false},{"nct_id":"NCT04886804","title":"Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":608,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}